Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.55 |
| ▸ | GAA | P10253 | 3/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | THRB | P10828 | 2/20 | 0.50 |
| ▸ | RECQL | P46063 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | PPARG | P37231 | 1/20 | 0.50 |
| ▸ | PPARA | Q07869 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8000660 | 0.86 | ALDH1A1 (0.76) | ALDH1A1MAPTKDM4EGAACYP3A4 | |
| SCHEMBL8718150 | 0.85 | ALDH1A1 (0.72) | ALDH1A1MAPTKDM4EGAACYP3A4 | |
| SCHEMBL98371 | 0.85 | ALDH1A1 (0.73) | ALDH1A1MAPTKDM4EGAACYP3A4 | |
| SCHEMBL8280033 | 0.85 | ALDH1A1 (0.73) | ALDH1A1MAPTKDM4EGAACYP3A4 | |
| SCHEMBL1354320 | 0.85 | ALDH1A1 (0.73) | ALDH1A1MAPTKDM4EGAAHPGD | |
| SCHEMBL6760942 | 0.84 | ALDH1A1 (0.70) | ALDH1A1MAPTKDM4EGAAHPGD | |
| SCHEMBL224165 | 0.83 | ALDH1A1 (0.71) | ALDH1A1MAPTKDM4EGAAHPGD | |
| Aminosalicylic Acid SCHEMBL6760940 | 0.83 | ALDH1A1 (0.69) | ALDH1A1MAPTKDM4EGAACYP3A4 | |
| SCHEMBL1443873 | 0.82 | ALDH1A1 (0.70) | ALDH1A1MAPTKDM4EGAACYP3A4 | |
| Hydrochloric Acid SCHEMBL7410231 | 0.81 | ALDH1A1 (0.69) | ALDH1A1MAPTKDM4EGAAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 783 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12264219-B2 | Conductive benzoic acid based polymer containing biomaterial for enhancement of tissue conduction in vitro and in vivo | UNIVERSITY HEALTH NETWORK (CA) | 2025-04-01 | — | — | US | claimed |
| EP-3658625-B1 | CONDUCTIVE BENZOIC ACID BASED POLYMER CONTAINING BIOMATERIAL FOR ENHANCEMENT OF TISSUE CONDUCTION IN VITRO AND IN VIVO | UNIV HEALTH NETWORK (CA) | 2024-06-12 | — | — | EP | claimed |
| CN-117801373-A | Preparation method and application of functionalized titanium dioxide | 河南龙兴钛业科技股份有限公司 | 2024-04-02 | — | — | CN | claimed |
| US-20210087336-A1 | CONDUCTIVE BENZOIC ACID BASED POLYMER CONTAINING BIOMATERIAL FOR ENHANCEMENT OF TISSUE CONDUCTION IN VITRO AND IN VIVO | UNIVERSITY HEALTH NETWORK (CA) | 2021-03-25 | — | — | US | claimed |
| EP-3658625-A1 | CONDUCTIVE BENZOIC ACID BASED POLYMER CONTAINING BIOMATERIAL FOR ENHANCEMENT OF TISSUE CONDUCTION IN VITRO AND IN VIVO | University Health Network (CA) | 2020-06-03 | — | — | EP | claimed |
| CN-110997810-A | Electrically conductive biomaterials comprising benzoic acid based polymers for enhancing tissue conductivity in vitro and in vivo | 大学健康网络 | 2020-04-10 | — | — | CN | claimed |
| CN-106011190-B | Preparation method of natural p-aminobenzoic acid and derivatives thereof | 福建师范大学 | 2020-02-07 | — | — | CN | claimed |
| WO-2019018942-A1 | CONDUCTIVE BENZOIC ACID BASED POLYMER CONTAINING BIOMATERIAL FOR ENHANCEMENT OF TISSUE CONDUCTION IN VITRO AND IN VIVO | UNIVERSITY HEALTH NETWORK (CA) | 2019-01-31 | — | — | WO | claimed |
| US-20180064667-A1 | METHODS OF TREATING LACTOSE INTOLERANCE | NOGRA PHARMA LTD (IE) | 2018-03-08 | — | — | US | claimed |
| CN-105705488-A | Acetylcholinesterase inhibitor compounds and 5HT4 serotonergic receptor agonisis, with promnesia effect, methods for the preparation thereof and pharmaceutical compositions containing same | 卡昂大学 | 2016-06-22 | — | — | CN | claimed |
| EP-1910275-A2 | COMPOUNDS AND THEIR SALTS SPECIFIC TO THE PPAR RECEPTORS AND THE EGF RECEPTORS AND THEIR USE IN THE MEDICAL FIELD | Giuliani International Limited (IE) | 2008-04-16 | — | — | EP | claimed |
| US-20080069968-A1 | Photocrosslinkable Materials | ROLIC AG (CH) | 2008-03-20 | — | — | US | claimed |
| CN-101040028-A | Photocrosslinkable materials | ROLIC AG (CH) | 2007-09-19 | — | — | CN | claimed |
| EP-1799791-A1 | PHOTOCROSSLINKABLE MATERIALS | Rolic AG (CH) | 2007-06-27 | — | — | EP | claimed |
| WO-2007010514-A2 | COMPOUNDS AND THEIR SALTS SPECIFIC TO THE PPAR RECEPTORS AND THE EGF RECEPTORS AND THEIR USE IN THE MEDICAL FIELD | GIULIANI INTERNATIONAL LIMITED (IE) | 2007-01-25 | — | — | WO | claimed |
| US-20060110743-A1 | Drug evolution: drug design at hot spots | KONISHI YASUO | 2006-05-25 | — | — | US | claimed |
| WO-2006039824-A1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2006-04-20 | — | — | WO | claimed |
| WO-2003016615-A1 | SINGLE BATH PROCESS FOR BLEACHING AND DYEING TEXTILES | NOVOZYMES NORTH AMERICA, INC. (US) | 2003-02-27 | — | — | WO | claimed |
| WO-2002095393-A2 | DRUG EVOLUTION: DRUG DESIGN AT HOT SPOTS | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2002-11-28 | — | — | WO | claimed |
| US-4036951-A | SUNSCREEN AGENTS | SYNERGISTICS, INC. (US) | 1977-07-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080069968-A1 | Photocrosslinkable Materials | PARG, VSIR, IGLV6-57 | ALDH1A1 1606/4885MAPT 467/4885KDM4E 844/4885 |
| US-20180064667-A1 | METHODS OF TREATING LACTOSE INTOLERANCE | LCT, LPL, PPARG | ALDH1A1 530/4885MAPT 4369/4885KDM4E 4341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.